James M. Mock

Insider Reports History

Location
Waltham, MA
Signature
/s/ James Dillon, As Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James M. Mock:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PERKINELMER INC Senior Vice President and Chief Financial Officer Common Stock 27.6K $3.79M $137.26 Jun 24, 2022 Direct
Moderna, Inc. Chief Financial Officer Common Stock 43.2K $1.1M $25.49 Dec 5, 2025 Direct
Moderna, Inc. Chief Financial Officer Restricted Stock Units 142K $299K $34.30 Dec 5, 2025 Direct
Moderna, Inc. Chief Financial Officer Performance Stock Units 0 $0 $33.58 Feb 27, 2025 Direct
Moderna, Inc. Chief Financial Officer Stock Option (Right to Buy) 63.5K Mar 1, 2025 Direct

Insider Reports Filed by James M. Mock

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRNA Moderna, Inc. Dec 5, 2025 3 -$582K 4 Dec 8, 2025 Chief Financial Officer
MRNA Moderna, Inc. Nov 26, 2025 6 -$13.3K 4 Dec 1, 2025 Chief Financial Officer
MRNA Moderna, Inc. Oct 3, 2025 3 -$19.9K 4 Oct 6, 2025 Chief Financial Officer
MRNA Moderna, Inc. Aug 27, 2025 6 -$13.3K 4 Aug 29, 2025 Chief Financial Officer
MRNA Moderna, Inc. Jul 3, 2025 3 -$21.3K 4 Jul 7, 2025 Chief Financial Officer
MRNA Moderna, Inc. May 27, 2025 6 -$14.1K 4 May 29, 2025 Chief Financial Officer
MRNA Moderna, Inc. Apr 4, 2025 3 -$18.1K 4 Apr 7, 2025 Chief Financial Officer
MRNA Moderna, Inc. Feb 28, 2025 5 -$4.97K 4 Mar 3, 2025 Chief Financial Officer
MRNA Moderna, Inc. Feb 27, 2025 9 -$93.4K 4 Feb 28, 2025 Chief Financial Officer
MRNA Moderna, Inc. Jan 3, 2025 3 -$32.8K 4 Jan 6, 2025 Chief Financial Officer
MRNA Moderna, Inc. Dec 5, 2024 1 $0 4 Dec 6, 2024 Chief Financial Officer
MRNA Moderna, Inc. Nov 27, 2024 7 -$60.8K 4 Dec 2, 2024 Chief Financial Officer
MRNA Moderna, Inc. Oct 4, 2024 3 -$43K 4 Oct 8, 2024 Chief Financial Officer
MRNA Moderna, Inc. Aug 28, 2024 3 -$12.6K 4 Aug 30, 2024 Chief Financial Officer
MRNA Moderna, Inc. Aug 27, 2024 5 -$105K 4 Aug 29, 2024 Chief Financial Officer
MRNA Moderna, Inc. Jul 5, 2024 3 -$81.5K 4 Jul 9, 2024 Chief Financial Officer
MRNA Moderna, Inc. May 31, 2024 4 -$97.2K 4 Jun 4, 2024 Chief Financial Officer
MRNA Moderna, Inc. May 28, 2024 3 -$26.4K 4 May 30, 2024 Chief Financial Officer
MRNA Moderna, Inc. May 24, 2024 3 -$105K 4 May 29, 2024 Chief Financial Officer
MRNA Moderna, Inc. Apr 5, 2024 3 -$71.9K 4 Apr 9, 2024 Chief Financial Officer
MRNA Moderna, Inc. Feb 28, 2024 3 -$61.2K 4 Mar 1, 2024 Chief Financial Officer
MRNA Moderna, Inc. Feb 27, 2024 4 $0 4 Feb 29, 2024 Chief Financial Officer
MRNA Moderna, Inc. Jan 5, 2024 3 -$84.7K 4 Jan 9, 2024 Chief Financial Officer
MRNA Moderna, Inc. Oct 5, 2023 3 -$293K 4 Oct 10, 2023 Chief Financial Officer
MRNA Moderna, Inc. Feb 28, 2023 2 $0 4 Mar 2, 2023 Chief Financial Officer
MRNA Moderna, Inc. Oct 5, 2022 2 $0 4 Oct 7, 2022 Chief Financial Officer
MRNA Moderna, Inc. Sep 6, 2022 0 $0 3 Sep 9, 2022 Chief Financial Officer
RVTY PERKINELMER INC Jun 24, 2022 3 -$731K 4 Jun 27, 2022 Senior Vice President and Chief Financial Officer
RVTY PERKINELMER INC Feb 4, 2022 5 -$1.18M 4 Feb 8, 2022 Officer
RVTY PERKINELMER INC Sep 20, 2021 6 -$1.12M 4 Sep 21, 2021 Senior Vice President and Chief Financial Officer
RVTY PERKINELMER INC May 17, 2021 1 -$575K 4 May 18, 2021 Senior Vice President and Chief Financial Officer